Renaissance Technologies’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$5.57M Buy
2,689,339
+414,839
+18% +$859K 0.01% 1458
2025
Q1
$5M Buy
2,274,500
+1,085,700
+91% +$2.39M 0.01% 1427
2024
Q4
$1.82M Sell
1,188,800
-819,398
-41% -$1.25M ﹤0.01% 2120
2024
Q3
$4M Buy
2,008,198
+14,398
+0.7% +$28.7K 0.01% 1587
2024
Q2
$6.98M Sell
1,993,800
-412,686
-17% -$1.44M 0.01% 1114
2024
Q1
$6.67M Buy
2,406,486
+523,186
+28% +$1.45M 0.01% 1233
2023
Q4
$3.2M Buy
1,883,300
+1,592,000
+547% +$2.71M 0.01% 1641
2023
Q3
$300K Sell
291,300
-767,800
-72% -$791K ﹤0.01% 2933
2023
Q2
$1.23M Sell
1,059,100
-81,736
-7% -$94.8K ﹤0.01% 2338
2023
Q1
$1.72M Buy
1,140,836
+814,336
+249% +$1.23M ﹤0.01% 2122
2022
Q4
$816K Buy
+326,500
New +$816K ﹤0.01% 2656
2021
Q2
Sell
-162,600
Closed -$2.64M 3600
2021
Q1
$2.64M Buy
+162,600
New +$2.64M ﹤0.01% 2041
2020
Q4
Sell
-134,800
Closed -$2M 3519
2020
Q3
$2M Sell
134,800
-105,000
-44% -$1.56M ﹤0.01% 2136
2020
Q2
$3.53M Sell
239,800
-812,092
-77% -$11.9M ﹤0.01% 1845
2020
Q1
$12.3M Buy
1,051,892
+870,892
+481% +$10.2M 0.01% 1033
2019
Q4
$4.25M Buy
+181,000
New +$4.25M ﹤0.01% 1956
2019
Q3
Sell
-97,400
Closed -$1.81M 3538
2019
Q2
$1.81M Buy
+97,400
New +$1.81M ﹤0.01% 2380
2018
Q4
Sell
-134,100
Closed -$4.24M 3464
2018
Q3
$4.24M Sell
134,100
-258,400
-66% -$8.18M ﹤0.01% 1910
2018
Q2
$15.2M Buy
+392,500
New +$15.2M 0.02% 1101
2018
Q1
Sell
-79,800
Closed -$1.44M 3446
2017
Q4
$1.44M Buy
+79,800
New +$1.44M ﹤0.01% 2508
2015
Q3
Sell
-48,100
Closed -$1.5M 3245
2015
Q2
$1.5M Buy
+48,100
New +$1.5M ﹤0.01% 2238